$BIIB
看多2020-11-04各周期结果✗ 踏空-5.6%
1d
✗ -2.7%
5d
✗ -0.7%
21d
✗ -5.6%
原帖
Neil Cataldi · 2020-11-04
Cogstate is likely a direct beneficiary of the positive $BIIB news re their Alzheimer’s drug. If approved, $COGZF should be their diagnostic partner in the US given that they already have a worldwide agreement with Eisai who is Biogens with Aducanumab. https://t.co/fNY3UMIzSY
在 X 查看 ↗